Diagnostic Imaging Devices - Brazil

In Brazil, the revenue of the Diagnostic Imaging Devices market market is estimated to reach US$1.10bn by 2024.
The market is projected to exhibit a compound annual growth rate (CAGR 2024-2029) of 5.37%, leading to a market volume of US$1.43bn by 2029.
When compared globally, the United States is anticipated to generate the highest revenue, amounting to US$11.93bn in 2024.
In Brazil, the demand for diagnostic imaging devices is growing steadily, driven by the increasing need for accurate and efficient medical diagnostics.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Brazil is experiencing significant growth due to several factors.

Customer preferences: Customers in Brazil are increasingly demanding advanced diagnostic imaging devices that provide accurate and detailed results. They value devices that offer high resolution images, quick and efficient scanning processes, and the ability to diagnose a wide range of medical conditions. Additionally, customers are seeking devices that are user-friendly and easy to operate, as well as those that are cost-effective and provide value for money.

Trends in the market: One of the key trends in the Diagnostic Imaging Devices market in Brazil is the increasing adoption of digital imaging technology. Digital imaging offers several advantages over traditional film-based imaging, including faster image acquisition, better image quality, and the ability to store and share images electronically. This trend is driven by the need for faster and more accurate diagnoses, as well as the growing demand for telemedicine services. Another trend in the market is the rising demand for portable and handheld imaging devices. These devices are compact, lightweight, and easy to use, making them ideal for use in remote and underserved areas. They are particularly valuable in Brazil, where access to healthcare facilities is limited in certain regions. Portable and handheld imaging devices enable healthcare professionals to provide diagnostic services in these areas, improving patient outcomes and reducing the need for patients to travel long distances for medical care.

Local special circumstances: Brazil has a large population and a growing middle class, which is driving the demand for healthcare services, including diagnostic imaging. The country also has a rapidly aging population, which is increasing the prevalence of age-related diseases and conditions that require diagnostic imaging. Additionally, Brazil has a high burden of non-communicable diseases such as cardiovascular diseases and cancer, which further contributes to the demand for diagnostic imaging devices.

Underlying macroeconomic factors: The Brazilian government has been investing in the healthcare sector, including the procurement of diagnostic imaging devices, to improve access to quality healthcare services. This investment is driven by the need to address the healthcare infrastructure gap in the country and improve healthcare outcomes for the population. Furthermore, the growing private healthcare sector in Brazil is also fueling the demand for diagnostic imaging devices, as private healthcare providers seek to offer advanced diagnostic services to their patients. In conclusion, the Diagnostic Imaging Devices market in Brazil is experiencing growth due to customer preferences for advanced and user-friendly devices, as well as the adoption of digital imaging technology. The rising demand for portable and handheld devices is also driving market growth, particularly in remote and underserved areas. Brazil's large population, growing middle class, and increasing burden of non-communicable diseases contribute to the demand for diagnostic imaging devices. The government's investment in healthcare infrastructure and the growth of the private healthcare sector are also key factors driving market growth.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.